Table 1.
Primers used in this study.
| Target | Sequence | Access Number |
|---|---|---|
| GATA3 | Fw: AGAAGGCAGGGAGTGTGTGA | NM_133293.1 |
| Rv: TTAGCGTTCCTCCTCCAGAG | ||
| Foxp3 | Fw: CGGGAGAGTTTCTCAAGCAC | NM_001108250.1 |
| Rv: CACAGGTGGAGCTTTTGTCA | ||
| T-bet | Fw: TCCAAGTTCAACCAGCACCA | NM_001107043.1 |
| Rv: ATAAGCGGTTCCCTGGCATA | ||
| RORγt | Fw: GCAGCAACGGGAACAAGTAG | XM_006232926.3 |
| Rv: GGGCTATACTCAAGGTGGCA | ||
| IgA-Fc | Fw: CGGAACTATGAATGTGACCT | AJ510151.1 |
| Rv: GACTAAGGAGGGTTTTGGAC | ||
| IgE-Fc | Fw: CGTCTGTCGGTTCTGATCTT | X00923.1 |
| Rv: GTCGCAGGATGAATGGAGTA | ||
| Mcpt2 | Fw: ATTATCGGTGGTGTGGAGTC | NM_172044.1 |
| Rv: GTGTGGATTCTCGCTTTCTC | ||
| IFN-γ | Fw: GCCTAGAAAGTCTGAAGAAC | NM_138880.2 |
| Rv: GAGATAATCTGGCTCTCAAG | ||
| TNF-α | Fw: GCCTCAGCCTCTTCTCAT | NM_012675.3 |
| Rv: CGCTTGGTGGTTTGCTACGA | ||
| IL-1β | Fw: AAATCTCACAGCAGCATCTC | NM_031512.2 |
| Rv: ACTAGCAGGTCGTCATCATC | ||
| IL-5 | Fw: CAGTGGTGAAAGAGACCTTG | NM_021834.1 |
| Rv: GTATGTCTAGCCCCTGAAAG | ||
| IL-13 | Fw: ATCGAGGAGCTGAGCAACAT | NM_053828.1 |
| Rv: ATCCGAGGCCTTTTGGTTAC | ||
| IL-17 | Fw: CGTGAAGGTCAACCTGAAAG | NM_001106897.1 |
| Rv: TCTATCAGGGTCCTCATTGC | ||
| IL-22 | Fw: CTCTGCCCATCAACTCCCAA | NM_001191988.1 |
| Rv: TTGGCTTTGACTCCTCGGAA | ||
| β-Actin | Fw: GTCGTACCACTGGCATTGTG | NM_031144.3 |
| Rv: GCTGTGGTGGTGAAGCTGTA |
Fc, fragment crystallizable.